Compliance with hormone replacement therapy after prophylactic oophorectomy

Journal of Obstetrics and Gynaecology

Volumn 19, Issue 3, 1999, Pages 301-302

  Hefni, M ^a   Apoola, A ^b   Davies, Angharad ^b   Mahadevan, S ^b   Ei Toukhy, T ^b  

^a Benenden Hospital   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; SEX HORMONE;

ADULT; AGED; ARTICLE; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; OVARIECTOMY; OVARY CANCER; PATIENT COMPLIANCE; PATIENT EDUCATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0033012005     PISSN: 01443615     EISSN: None     Source Type: Journal    
DOI: 10.1080/01443619965147     Document Type: Article

References (5)

1. Griffiths F. and Convery B. (1995) Women's use of hormone replacement therapy for relief of menopausal symptoms, for prevention of osteoporosis, and after hysterectomy. British Journal of General Practitioners, 45, 355-358.
2. Jacobs I. and Oram D. (1989) Prevention of ovarian cancer: a survery of the practice of prophylactic oophorectomy by fellows and members of the Royal College of Obstetricians and Gynaccologists. British Journal of Obstetrics and Gynaecology, 96, 510 515.
3. Randall C. L. (1963) Ovarian conservation. In: Progress in Gynecology, Volume IV, edited by Meigs J. V. and Sturgis S.H., pp. 457 464. London, Heinemann.
4. Spector T. D. (1989) Use of oestrogen replacement therapy in high risk groups in the United Kingdom. British Medical Journal, 299, 1434-1435.
5. Tang M., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H. and Mayeux R. (1996) Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet, 348, 429 432.